Xspray Pharma AB (publ) filed its Annual on Mar 29, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
76.3 SEK | -1.55% | -9.06% | +90.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.75% | 25Cr | |
+16.42% | 12TCr | |
+19.02% | 11TCr | |
+2.42% | 2.27TCr | |
-11.63% | 1.67TCr | |
-16.33% | 1.66TCr | |
-39.57% | 1.69TCr | |
+2.68% | 1.36TCr | |
+21.16% | 1.1TCr | |
+108.78% | 1.04TCr |
- Stock Market
- Equities
- XSPRAY Stock
- News Xspray Pharma AB
- Xspray Pharma AB Auditor Raises 'Going Concern' Doubt